Androgen Antagonistic Effect of Estramustine Phosphate (EMP) Metabolites on Wild-Type and Mutated Androgen Receptor
Open Access
- 1 May 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (9) , 1427-1433
- https://doi.org/10.1016/s0006-2952(97)00657-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell linesPublished by Wiley ,1997
- Induction of differentiation and down-regulation of c-myb gene expression in ML-1 human myeloblastic leukemia cells by the clinically effective anti-leukemia agent meisoindigoBiochemical Pharmacology, 1996
- Synergism between androgens and protein kinase-C on androgen-regulated gene expressionMolecular and Cellular Endocrinology, 1995
- Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activationBiochemistry, 1992
- The Promoter of the Prostate-Specific Antigen Gene Contains a Functional Androgen Responsive ElementMolecular Endocrinology, 1991
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988
- Effect of estramustine phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP2, or the tubulin-binding fragment of MAP2Archives of Biochemistry and Biophysics, 1987
- Clinical pharmacokinetics of estramustine phosphateUrology, 1984
- Estramustine‐induced mitotic arrest in two human prostatic carcinoma cell lines du 145 and PC‐3The Prostate, 1984
- The hydrolysis of estramustine phosphate; in vitro studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1983